nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP3A4—bone cancer	0.932	1	CbGaD
Dextropropoxyphene—Liver injury—Cisplatin—bone cancer	0.00127	0.0262	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Cisplatin—bone cancer	0.00107	0.022	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Cisplatin—bone cancer	0.000853	0.0176	CcSEcCtD
Dextropropoxyphene—Toremifene—CYP3A4—bone cancer	0.000783	0.1	CrCbGaD
Dextropropoxyphene—Gastrointestinal haemorrhage—Cisplatin—bone cancer	0.000774	0.016	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Epirubicin—bone cancer	0.000773	0.016	CcSEcCtD
Dextropropoxyphene—Alimemazine—CYP3A4—bone cancer	0.000735	0.0941	CrCbGaD
Dextropropoxyphene—Hepatomegaly—Doxorubicin—bone cancer	0.000716	0.0148	CcSEcCtD
Dextropropoxyphene—CYP3A7—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000673	0.0588	CbGpPWpGaD
Dextropropoxyphene—Liver injury—Epirubicin—bone cancer	0.00065	0.0134	CcSEcCtD
Dextropropoxyphene—Disopyramide—CYP3A4—bone cancer	0.000649	0.0832	CrCbGaD
Dextropropoxyphene—Jaundice cholestatic—Epirubicin—bone cancer	0.000623	0.0129	CcSEcCtD
Dextropropoxyphene—Liver injury—Doxorubicin—bone cancer	0.000602	0.0124	CcSEcCtD
Dextropropoxyphene—Phenylbutazone—CYP3A4—bone cancer	0.00059	0.0757	CrCbGaD
Dextropropoxyphene—Acute coronary syndrome—Cisplatin—bone cancer	0.000588	0.0121	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Cisplatin—bone cancer	0.000584	0.0121	CcSEcCtD
Dextropropoxyphene—Phenylbutazone—PTGS2—bone cancer	0.000578	0.0741	CrCbGaD
Dextropropoxyphene—Jaundice cholestatic—Doxorubicin—bone cancer	0.000576	0.0119	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Cisplatin—bone cancer	0.000564	0.0117	CcSEcCtD
Dextropropoxyphene—Propafenone—CYP3A4—bone cancer	0.000552	0.0707	CrCbGaD
Dextropropoxyphene—Hepatocellular injury—Epirubicin—bone cancer	0.000547	0.0113	CcSEcCtD
Dextropropoxyphene—Bradycardia—Cisplatin—bone cancer	0.000545	0.0113	CcSEcCtD
Dextropropoxyphene—Coma—Methotrexate—bone cancer	0.000534	0.011	CcSEcCtD
Dextropropoxyphene—Levomethadyl Acetate—CYP3A4—bone cancer	0.000529	0.0678	CrCbGaD
Dextropropoxyphene—Visual impairment—Cisplatin—bone cancer	0.000516	0.0107	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Doxorubicin—bone cancer	0.000506	0.0105	CcSEcCtD
Dextropropoxyphene—Eye disorder—Cisplatin—bone cancer	0.0005	0.0103	CcSEcCtD
Dextropropoxyphene—Coma—Epirubicin—bone cancer	0.0005	0.0103	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Cisplatin—bone cancer	0.000497	0.0103	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Cisplatin—bone cancer	0.000483	0.00999	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Cisplatin—bone cancer	0.000482	0.00997	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Cisplatin—bone cancer	0.000478	0.00988	CcSEcCtD
Dextropropoxyphene—Malnutrition—Cisplatin—bone cancer	0.000466	0.00963	CcSEcCtD
Dextropropoxyphene—Coma—Doxorubicin—bone cancer	0.000463	0.00957	CcSEcCtD
Dextropropoxyphene—Modafinil—CYP3A4—bone cancer	0.000462	0.0593	CrCbGaD
Dextropropoxyphene—Hepatic function abnormal—Epirubicin—bone cancer	0.000455	0.0094	CcSEcCtD
Dextropropoxyphene—Fentanyl—CYP3A4—bone cancer	0.000452	0.058	CrCbGaD
Dextropropoxyphene—Visual disturbance—Methotrexate—bone cancer	0.000448	0.00926	CcSEcCtD
Dextropropoxyphene—Vision blurred—Cisplatin—bone cancer	0.000439	0.00908	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Epirubicin—bone cancer	0.000438	0.00906	CcSEcCtD
Dextropropoxyphene—Loperamide—CYP3A4—bone cancer	0.000436	0.0558	CrCbGaD
Dextropropoxyphene—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000421	0.0368	CbGpPWpGaD
Dextropropoxyphene—Hepatic function abnormal—Doxorubicin—bone cancer	0.000421	0.0087	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Doxorubicin—bone cancer	0.000405	0.00838	CcSEcCtD
Dextropropoxyphene—Convulsion—Cisplatin—bone cancer	0.000404	0.00834	CcSEcCtD
Dextropropoxyphene—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000403	0.0352	CbGpPWpGaD
Dextropropoxyphene—Benzphetamine—CYP3A4—bone cancer	0.000401	0.0514	CrCbGaD
Dextropropoxyphene—Ataxia—Methotrexate—bone cancer	0.000399	0.00825	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.000397	0.00821	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Methotrexate—bone cancer	0.000392	0.0081	CcSEcCtD
Dextropropoxyphene—Discomfort—Cisplatin—bone cancer	0.000392	0.0081	CcSEcCtD
Dextropropoxyphene—Phenoxybenzamine—CYP3A4—bone cancer	0.000383	0.0491	CrCbGaD
Dextropropoxyphene—Cardiac arrest—Epirubicin—bone cancer	0.000378	0.00781	CcSEcCtD
Dextropropoxyphene—Ataxia—Epirubicin—bone cancer	0.000374	0.00772	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Cisplatin—bone cancer	0.000373	0.00771	CcSEcCtD
Dextropropoxyphene—Tachycardia—Cisplatin—bone cancer	0.000371	0.00767	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000368	0.0076	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Epirubicin—bone cancer	0.000367	0.00758	CcSEcCtD
Dextropropoxyphene—Hypotension—Cisplatin—bone cancer	0.000355	0.00735	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Doxorubicin—bone cancer	0.00035	0.00723	CcSEcCtD
Dextropropoxyphene—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000347	0.0304	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000346	0.0302	CbGpPWpGaD
Dextropropoxyphene—Ataxia—Doxorubicin—bone cancer	0.000346	0.00715	CcSEcCtD
Dextropropoxyphene—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000343	0.03	CbGpPWpGaD
Dextropropoxyphene—Liver function test abnormal—Doxorubicin—bone cancer	0.000339	0.00702	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Cisplatin—bone cancer	0.000339	0.00701	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Cisplatin—bone cancer	0.000328	0.00679	CcSEcCtD
Dextropropoxyphene—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000328	0.0286	CbGpPWpGaD
Dextropropoxyphene—Drowsiness—Methotrexate—bone cancer	0.000327	0.00676	CcSEcCtD
Dextropropoxyphene—Trimipramine—CYP3A4—bone cancer	0.000327	0.0419	CrCbGaD
Dextropropoxyphene—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.000325	0.0284	CbGpPWpGaD
Dextropropoxyphene—Feeling abnormal—Cisplatin—bone cancer	0.000313	0.00648	CcSEcCtD
Dextropropoxyphene—Tamoxifen—CYP3A4—bone cancer	0.000313	0.0401	CrCbGaD
Dextropropoxyphene—Methadone—CYP3A4—bone cancer	0.00031	0.0397	CrCbGaD
Dextropropoxyphene—Hepatobiliary disease—Methotrexate—bone cancer	0.000309	0.0064	CcSEcCtD
Dextropropoxyphene—Drowsiness—Epirubicin—bone cancer	0.000306	0.00633	CcSEcCtD
Dextropropoxyphene—Orphenadrine—CYP3A4—bone cancer	0.000304	0.0389	CrCbGaD
Dextropropoxyphene—Jaundice—Epirubicin—bone cancer	0.000298	0.00617	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Epirubicin—bone cancer	0.00029	0.00599	CcSEcCtD
Dextropropoxyphene—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	0.000289	0.0253	CbGpPWpGaD
Dextropropoxyphene—Drowsiness—Doxorubicin—bone cancer	0.000283	0.00586	CcSEcCtD
Dextropropoxyphene—Visual impairment—Methotrexate—bone cancer	0.000283	0.00585	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Cisplatin—bone cancer	0.00028	0.00579	CcSEcCtD
Dextropropoxyphene—Bradycardia—Epirubicin—bone cancer	0.00028	0.00578	CcSEcCtD
Dextropropoxyphene—Jaundice—Doxorubicin—bone cancer	0.000276	0.00571	CcSEcCtD
Dextropropoxyphene—Eye disorder—Methotrexate—bone cancer	0.000274	0.00567	CcSEcCtD
Dextropropoxyphene—Asthenia—Cisplatin—bone cancer	0.000273	0.00564	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Methotrexate—bone cancer	0.000273	0.00563	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Doxorubicin—bone cancer	0.000268	0.00554	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Methotrexate—bone cancer	0.000265	0.00548	CcSEcCtD
Dextropropoxyphene—Visual impairment—Epirubicin—bone cancer	0.000265	0.00548	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Methotrexate—bone cancer	0.000265	0.00547	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Cisplatin—bone cancer	0.00026	0.00538	CcSEcCtD
Dextropropoxyphene—Bradycardia—Doxorubicin—bone cancer	0.000259	0.00535	CcSEcCtD
Dextropropoxyphene—Eye disorder—Epirubicin—bone cancer	0.000257	0.00531	CcSEcCtD
Dextropropoxyphene—Malnutrition—Methotrexate—bone cancer	0.000256	0.00529	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Epirubicin—bone cancer	0.000255	0.00527	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Epirubicin—bone cancer	0.000248	0.00513	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Epirubicin—bone cancer	0.000248	0.00512	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Epirubicin—bone cancer	0.000246	0.00508	CcSEcCtD
Dextropropoxyphene—Visual impairment—Doxorubicin—bone cancer	0.000245	0.00507	CcSEcCtD
Dextropropoxyphene—OPRK1—Mecp2 and Associated Rett Syndrome—EZH2—bone cancer	0.000243	0.0213	CbGpPWpGaD
Dextropropoxyphene—Vomiting—Cisplatin—bone cancer	0.000242	0.005	CcSEcCtD
Dextropropoxyphene—Vision blurred—Methotrexate—bone cancer	0.000241	0.00498	CcSEcCtD
Dextropropoxyphene—Rash—Cisplatin—bone cancer	0.00024	0.00496	CcSEcCtD
Dextropropoxyphene—Dermatitis—Cisplatin—bone cancer	0.00024	0.00495	CcSEcCtD
Dextropropoxyphene—Malnutrition—Epirubicin—bone cancer	0.000239	0.00495	CcSEcCtD
Dextropropoxyphene—Eye disorder—Doxorubicin—bone cancer	0.000238	0.00491	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Doxorubicin—bone cancer	0.000236	0.00488	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Doxorubicin—bone cancer	0.00023	0.00475	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Doxorubicin—bone cancer	0.000229	0.00474	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Doxorubicin—bone cancer	0.000227	0.0047	CcSEcCtD
Dextropropoxyphene—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000226	0.0198	CbGpPWpGaD
Dextropropoxyphene—Nausea—Cisplatin—bone cancer	0.000226	0.00467	CcSEcCtD
Dextropropoxyphene—Vision blurred—Epirubicin—bone cancer	0.000226	0.00466	CcSEcCtD
Dextropropoxyphene—Convulsion—Methotrexate—bone cancer	0.000222	0.00458	CcSEcCtD
Dextropropoxyphene—Malnutrition—Doxorubicin—bone cancer	0.000221	0.00458	CcSEcCtD
Dextropropoxyphene—Agitation—Epirubicin—bone cancer	0.00022	0.00455	CcSEcCtD
Dextropropoxyphene—Discomfort—Methotrexate—bone cancer	0.000215	0.00445	CcSEcCtD
Dextropropoxyphene—Syncope—Epirubicin—bone cancer	0.000215	0.00444	CcSEcCtD
Dextropropoxyphene—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000213	0.0186	CbGpPWpGaD
Dextropropoxyphene—Confusional state—Methotrexate—bone cancer	0.00021	0.00435	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Epirubicin—bone cancer	0.00021	0.00435	CcSEcCtD
Dextropropoxyphene—Vision blurred—Doxorubicin—bone cancer	0.000209	0.00431	CcSEcCtD
Dextropropoxyphene—Convulsion—Epirubicin—bone cancer	0.000207	0.00429	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Methotrexate—bone cancer	0.000205	0.00423	CcSEcCtD
Dextropropoxyphene—Agitation—Doxorubicin—bone cancer	0.000203	0.00421	CcSEcCtD
Dextropropoxyphene—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000203	0.0178	CbGpPWpGaD
Dextropropoxyphene—Discomfort—Epirubicin—bone cancer	0.000201	0.00416	CcSEcCtD
Dextropropoxyphene—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000199	0.0174	CbGpPWpGaD
Dextropropoxyphene—Syncope—Doxorubicin—bone cancer	0.000199	0.0041	CcSEcCtD
Dextropropoxyphene—Confusional state—Epirubicin—bone cancer	0.000197	0.00407	CcSEcCtD
Dextropropoxyphene—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000195	0.0171	CbGpPWpGaD
Dextropropoxyphene—Hypotension—Methotrexate—bone cancer	0.000195	0.00403	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Doxorubicin—bone cancer	0.000195	0.00402	CcSEcCtD
Dextropropoxyphene—Shock—Epirubicin—bone cancer	0.000192	0.00397	CcSEcCtD
Dextropropoxyphene—Convulsion—Doxorubicin—bone cancer	0.000192	0.00397	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Epirubicin—bone cancer	0.000192	0.00396	CcSEcCtD
Dextropropoxyphene—Tachycardia—Epirubicin—bone cancer	0.000191	0.00394	CcSEcCtD
Dextropropoxyphene—Insomnia—Methotrexate—bone cancer	0.000189	0.0039	CcSEcCtD
Dextropropoxyphene—Discomfort—Doxorubicin—bone cancer	0.000186	0.00385	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Methotrexate—bone cancer	0.000186	0.00385	CcSEcCtD
Dextropropoxyphene—Somnolence—Methotrexate—bone cancer	0.000186	0.00383	CcSEcCtD
Dextropropoxyphene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000185	0.0162	CbGpPWpGaD
Dextropropoxyphene—Dyspepsia—Methotrexate—bone cancer	0.000184	0.0038	CcSEcCtD
Dextropropoxyphene—Hypotension—Epirubicin—bone cancer	0.000182	0.00377	CcSEcCtD
Dextropropoxyphene—Confusional state—Doxorubicin—bone cancer	0.000182	0.00377	CcSEcCtD
Dextropropoxyphene—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000181	0.0158	CbGpPWpGaD
Dextropropoxyphene—Gastrointestinal disorder—Methotrexate—bone cancer	0.00018	0.00372	CcSEcCtD
Dextropropoxyphene—Shock—Doxorubicin—bone cancer	0.000178	0.00367	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Doxorubicin—bone cancer	0.000177	0.00366	CcSEcCtD
Dextropropoxyphene—Insomnia—Epirubicin—bone cancer	0.000177	0.00365	CcSEcCtD
Dextropropoxyphene—Tachycardia—Doxorubicin—bone cancer	0.000176	0.00365	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Epirubicin—bone cancer	0.000174	0.0036	CcSEcCtD
Dextropropoxyphene—Somnolence—Epirubicin—bone cancer	0.000174	0.00359	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Methotrexate—bone cancer	0.000172	0.00355	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Epirubicin—bone cancer	0.000172	0.00355	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Methotrexate—bone cancer	0.000171	0.00353	CcSEcCtD
Dextropropoxyphene—Hypotension—Doxorubicin—bone cancer	0.000169	0.00349	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Epirubicin—bone cancer	0.000169	0.00348	CcSEcCtD
Dextropropoxyphene—Constipation—Epirubicin—bone cancer	0.000167	0.00345	CcSEcCtD
Dextropropoxyphene—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000167	0.0146	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000165	0.0145	CbGpPWpGaD
Dextropropoxyphene—Abdominal pain—Methotrexate—bone cancer	0.000165	0.00341	CcSEcCtD
Dextropropoxyphene—Insomnia—Doxorubicin—bone cancer	0.000163	0.00338	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Doxorubicin—bone cancer	0.000161	0.00333	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Epirubicin—bone cancer	0.000161	0.00333	CcSEcCtD
Dextropropoxyphene—Somnolence—Doxorubicin—bone cancer	0.000161	0.00332	CcSEcCtD
Dextropropoxyphene—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.00016	0.014	CbGpPWpGaD
Dextropropoxyphene—Gastrointestinal pain—Epirubicin—bone cancer	0.00016	0.0033	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Doxorubicin—bone cancer	0.000159	0.00329	CcSEcCtD
Dextropropoxyphene—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000159	0.0139	CbGpPWpGaD
Dextropropoxyphene—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000156	0.00322	CcSEcCtD
Dextropropoxyphene—Constipation—Doxorubicin—bone cancer	0.000155	0.00319	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Epirubicin—bone cancer	0.000154	0.00319	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Methotrexate—bone cancer	0.000154	0.00318	CcSEcCtD
Dextropropoxyphene—Asthenia—Methotrexate—bone cancer	0.00015	0.00309	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Doxorubicin—bone cancer	0.000149	0.00308	CcSEcCtD
Dextropropoxyphene—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000149	0.013	CbGpPWpGaD
Dextropropoxyphene—Gastrointestinal pain—Doxorubicin—bone cancer	0.000148	0.00305	CcSEcCtD
Dextropropoxyphene—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000147	0.0129	CbGpPWpGaD
Dextropropoxyphene—Hypersensitivity—Epirubicin—bone cancer	0.000144	0.00297	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Doxorubicin—bone cancer	0.000143	0.00295	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Methotrexate—bone cancer	0.000143	0.00295	CcSEcCtD
Dextropropoxyphene—Asthenia—Epirubicin—bone cancer	0.00014	0.0029	CcSEcCtD
Dextropropoxyphene—OPRD1—G alpha (i) signalling events—RGS1—bone cancer	0.00014	0.0122	CbGpPWpGaD
Dextropropoxyphene—OPRD1—G alpha (i) signalling events—GRM4—bone cancer	0.00014	0.0122	CbGpPWpGaD
Dextropropoxyphene—Dizziness—Methotrexate—bone cancer	0.000138	0.00285	CcSEcCtD
Dextropropoxyphene—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000135	0.0118	CbGpPWpGaD
Dextropropoxyphene—Diarrhoea—Epirubicin—bone cancer	0.000134	0.00276	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Doxorubicin—bone cancer	0.000133	0.00275	CcSEcCtD
Dextropropoxyphene—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000133	0.0116	CbGpPWpGaD
Dextropropoxyphene—Vomiting—Methotrexate—bone cancer	0.000133	0.00274	CcSEcCtD
Dextropropoxyphene—Rash—Methotrexate—bone cancer	0.000132	0.00272	CcSEcCtD
Dextropropoxyphene—Dermatitis—Methotrexate—bone cancer	0.000131	0.00272	CcSEcCtD
Dextropropoxyphene—Headache—Methotrexate—bone cancer	0.000131	0.0027	CcSEcCtD
Dextropropoxyphene—Asthenia—Doxorubicin—bone cancer	0.00013	0.00268	CcSEcCtD
Dextropropoxyphene—Dizziness—Epirubicin—bone cancer	0.000129	0.00267	CcSEcCtD
Dextropropoxyphene—Vomiting—Epirubicin—bone cancer	0.000124	0.00257	CcSEcCtD
Dextropropoxyphene—Nausea—Methotrexate—bone cancer	0.000124	0.00256	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Doxorubicin—bone cancer	0.000124	0.00256	CcSEcCtD
Dextropropoxyphene—Rash—Epirubicin—bone cancer	0.000123	0.00255	CcSEcCtD
Dextropropoxyphene—Dermatitis—Epirubicin—bone cancer	0.000123	0.00254	CcSEcCtD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—GRM4—bone cancer	0.000123	0.0107	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—RGS1—bone cancer	0.000123	0.0107	CbGpPWpGaD
Dextropropoxyphene—Headache—Epirubicin—bone cancer	0.000122	0.00253	CcSEcCtD
Dextropropoxyphene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000122	0.0107	CbGpPWpGaD
Dextropropoxyphene—Dizziness—Doxorubicin—bone cancer	0.000119	0.00247	CcSEcCtD
Dextropropoxyphene—Nausea—Epirubicin—bone cancer	0.000116	0.0024	CcSEcCtD
Dextropropoxyphene—Vomiting—Doxorubicin—bone cancer	0.000115	0.00237	CcSEcCtD
Dextropropoxyphene—Rash—Doxorubicin—bone cancer	0.000114	0.00235	CcSEcCtD
Dextropropoxyphene—Dermatitis—Doxorubicin—bone cancer	0.000114	0.00235	CcSEcCtD
Dextropropoxyphene—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000114	0.00993	CbGpPWpGaD
Dextropropoxyphene—Headache—Doxorubicin—bone cancer	0.000113	0.00234	CcSEcCtD
Dextropropoxyphene—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000109	0.00955	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000108	0.00946	CbGpPWpGaD
Dextropropoxyphene—Nausea—Doxorubicin—bone cancer	0.000107	0.00222	CcSEcCtD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—GRM4—bone cancer	0.000104	0.00907	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—RGS1—bone cancer	0.000104	0.00907	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	9.73e-05	0.0085	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—GRM4—bone cancer	8.48e-05	0.00741	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	8.44e-05	0.00738	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	8.33e-05	0.00728	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—GRM4—bone cancer	7.44e-05	0.0065	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—GRM1—bone cancer	7.35e-05	0.00643	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	6.93e-05	0.00606	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	6.87e-05	0.006	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	6.84e-05	0.00598	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	6.84e-05	0.00598	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	6.78e-05	0.00593	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—GRM1—bone cancer	6.45e-05	0.00564	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—GRM4—bone cancer	6.28e-05	0.00549	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Biological oxidations—CYP3A4—bone cancer	5.8e-05	0.00507	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	5.72e-05	0.005	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	5.62e-05	0.00491	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	5.57e-05	0.00487	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—GRM1—bone cancer	5.45e-05	0.00476	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—SMO—bone cancer	5.18e-05	0.00453	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Biological oxidations—GSTP1—bone cancer	4.96e-05	0.00434	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	4.9e-05	0.00428	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—GRM4—bone cancer	4.79e-05	0.00419	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—RGS1—bone cancer	4.79e-05	0.00419	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—SMO—bone cancer	4.54e-05	0.00397	CbGpPWpGaD
Dextropropoxyphene—OPRM1—TCR Signaling Pathway—JUN—bone cancer	4.53e-05	0.00396	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—RGS1—bone cancer	4.35e-05	0.0038	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—GRM4—bone cancer	4.35e-05	0.0038	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	4.33e-05	0.00378	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—RGS1—bone cancer	4.2e-05	0.00367	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—GRM4—bone cancer	4.2e-05	0.00367	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—GRM1—bone cancer	4.15e-05	0.00363	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—SMO—bone cancer	3.84e-05	0.00336	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—GRM4—bone cancer	3.82e-05	0.00334	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—RGS1—bone cancer	3.82e-05	0.00334	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—GRM1—bone cancer	3.77e-05	0.0033	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—GRM1—bone cancer	3.64e-05	0.00319	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Biological oxidations—CYP3A4—bone cancer	3.63e-05	0.00318	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	3.58e-05	0.00313	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—GRM4—bone cancer	3.55e-05	0.0031	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—RGS1—bone cancer	3.55e-05	0.0031	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	3.52e-05	0.00308	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—NDUFA12—bone cancer	3.48e-05	0.00304	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—GRM1—bone cancer	3.31e-05	0.00289	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—GRM4—bone cancer	3.22e-05	0.00282	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—RGS1—bone cancer	3.22e-05	0.00282	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Biological oxidations—GSTP1—bone cancer	3.11e-05	0.00272	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—GRM1—bone cancer	3.08e-05	0.00269	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	3.06e-05	0.00268	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Biological oxidations—CYP3A4—bone cancer	2.98e-05	0.00261	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Biological oxidations—CYP3A4—bone cancer	2.96e-05	0.00259	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	2.94e-05	0.00257	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	2.92e-05	0.00255	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—NT5C3A—bone cancer	2.88e-05	0.00252	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—GRM1—bone cancer	2.8e-05	0.00244	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—GNA11—bone cancer	2.68e-05	0.00234	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—SMO—bone cancer	2.66e-05	0.00232	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	2.57e-05	0.00225	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—GRM4—bone cancer	2.57e-05	0.00225	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—RGS1—bone cancer	2.57e-05	0.00225	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Biological oxidations—GSTP1—bone cancer	2.55e-05	0.00223	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Biological oxidations—GSTP1—bone cancer	2.53e-05	0.00221	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	2.52e-05	0.0022	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	2.49e-05	0.00218	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—GNA11—bone cancer	2.43e-05	0.00213	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—IL3—bone cancer	2.43e-05	0.00212	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—GNA11—bone cancer	2.35e-05	0.00205	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—SMO—bone cancer	2.33e-05	0.00204	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—GRM4—bone cancer	2.25e-05	0.00197	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—RGS1—bone cancer	2.25e-05	0.00197	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—GRM1—bone cancer	2.23e-05	0.00195	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL3—bone cancer	2.2e-05	0.00193	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—NDUFA12—bone cancer	2.18e-05	0.0019	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—GNA11—bone cancer	2.13e-05	0.00186	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—IL3—bone cancer	2.13e-05	0.00186	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—GNA11—bone cancer	1.98e-05	0.00173	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—SMO—bone cancer	1.97e-05	0.00172	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—GRM1—bone cancer	1.95e-05	0.00171	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL3—bone cancer	1.93e-05	0.00169	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—GRM4—bone cancer	1.9e-05	0.00167	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—RGS1—bone cancer	1.9e-05	0.00167	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—NT5C3A—bone cancer	1.8e-05	0.00158	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—GNA11—bone cancer	1.8e-05	0.00158	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—IL3—bone cancer	1.8e-05	0.00157	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NDUFA12—bone cancer	1.79e-05	0.00156	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NDUFA12—bone cancer	1.77e-05	0.00155	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Biological oxidations—GSTP1—bone cancer	1.67e-05	0.00146	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—GRM1—bone cancer	1.65e-05	0.00144	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	1.65e-05	0.00144	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL3—bone cancer	1.63e-05	0.00143	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SMO—bone cancer	1.57e-05	0.00137	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NT5C3A—bone cancer	1.48e-05	0.0013	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NT5C3A—bone cancer	1.47e-05	0.00128	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—GNA11—bone cancer	1.44e-05	0.00126	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SMO—bone cancer	1.38e-05	0.0012	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—ATF1—bone cancer	1.34e-05	0.00117	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL3—bone cancer	1.3e-05	0.00114	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ENO2—bone cancer	1.26e-05	0.0011	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—GNA11—bone cancer	1.26e-05	0.0011	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—DHFR—bone cancer	1.17e-05	0.00102	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ATF1—bone cancer	1.17e-05	0.00102	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NDUFA12—bone cancer	1.17e-05	0.00102	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SMO—bone cancer	1.16e-05	0.00102	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL3—bone cancer	1.14e-05	0.000998	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TGFBR2—bone cancer	1.11e-05	0.000974	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GNA11—bone cancer	1.09e-05	0.000957	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—GNA11—bone cancer	1.06e-05	0.000931	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IGF1R—bone cancer	1.05e-05	0.000916	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CYP3A4—bone cancer	9.92e-06	0.000868	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ATF1—bone cancer	9.89e-06	0.000865	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TGFBR2—bone cancer	9.76e-06	0.000854	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NT5C3A—bone cancer	9.69e-06	0.000847	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL3—bone cancer	9.65e-06	0.000844	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IGF1R—bone cancer	9.19e-06	0.000803	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GSTP1—bone cancer	8.49e-06	0.000742	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TGFBR2—bone cancer	8.25e-06	0.000722	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ENO2—bone cancer	7.91e-06	0.000691	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IGF1R—bone cancer	7.76e-06	0.000679	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—KIT—bone cancer	7.6e-06	0.000664	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—DHFR—bone cancer	7.33e-06	0.000641	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—BRAF—bone cancer	7.14e-06	0.000624	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—EGFR—bone cancer	6.92e-06	0.000605	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GNA11—bone cancer	6.85e-06	0.000599	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—KIT—bone cancer	6.66e-06	0.000583	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ENO2—bone cancer	6.49e-06	0.000567	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ENO2—bone cancer	6.43e-06	0.000563	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—BRAF—bone cancer	6.26e-06	0.000548	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYP3A4—bone cancer	6.21e-06	0.000543	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.18e-06	0.000541	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—EGFR—bone cancer	6.07e-06	0.000531	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—DHFR—bone cancer	6.02e-06	0.000526	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MDM2—bone cancer	5.98e-06	0.000523	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—DHFR—bone cancer	5.97e-06	0.000522	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—KIT—bone cancer	5.63e-06	0.000492	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GNA11—bone cancer	5.63e-06	0.000492	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GNA11—bone cancer	5.58e-06	0.000488	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTP1—bone cancer	5.31e-06	0.000465	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—BRAF—bone cancer	5.29e-06	0.000463	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MDM2—bone cancer	5.25e-06	0.000459	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—JUN—bone cancer	5.2e-06	0.000455	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—EGFR—bone cancer	5.13e-06	0.000449	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP3A4—bone cancer	5.1e-06	0.000446	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MMP9—bone cancer	5.06e-06	0.000442	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP3A4—bone cancer	5.06e-06	0.000442	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.03e-06	0.00044	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—JUN—bone cancer	4.56e-06	0.000399	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MMP9—bone cancer	4.44e-06	0.000388	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MDM2—bone cancer	4.43e-06	0.000388	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTGS2—bone cancer	4.4e-06	0.000384	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTP1—bone cancer	4.36e-06	0.000381	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTP1—bone cancer	4.33e-06	0.000378	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ENO2—bone cancer	4.24e-06	0.000371	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EGFR—bone cancer	4.09e-06	0.000358	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—DHFR—bone cancer	3.94e-06	0.000344	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—JUN—bone cancer	3.85e-06	0.000337	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MMP9—bone cancer	3.75e-06	0.000328	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GNA11—bone cancer	3.68e-06	0.000322	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EGFR—bone cancer	3.59e-06	0.000314	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TP53—bone cancer	3.43e-06	0.0003	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EGFR—bone cancer	3.03e-06	0.000265	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TP53—bone cancer	3.01e-06	0.000263	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTP1—bone cancer	2.85e-06	0.000249	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTGS2—bone cancer	2.75e-06	0.000241	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TP53—bone cancer	2.54e-06	0.000222	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTGS2—bone cancer	2.26e-06	0.000198	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTGS2—bone cancer	2.24e-06	0.000196	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTGS2—bone cancer	1.48e-06	0.000129	CbGpPWpGaD
